Beta Bionics (BBNX) Share-based Compensation (2024 - 2026)

Beta Bionics' Share-based Compensation history runs 3 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 92.8% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $19.0 million (up 142.45% YoY), while the FY2025 annual figure was $16.4 million, up 156.64% from the prior year.
• Share-based Compensation came in at $5.4 million for Q1 2026 at Beta Bionics, up from $4.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.4 million in Q1 2026 to a low of $1.4 million in Q1 2024.
• A 3-year average of $3.1 million and a median of $2.8 million in 2025 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation surged 220.15% in 2025 and surged 92.8% in 2026, its largest moves.
• Beta Bionics' Share-based Compensation stood at $1.6 million in 2024, then soared by 177.26% to $4.3 million in 2025, then grew by 25.63% to $5.4 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $5.4 million, $4.3 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison